• Telix to change reporting currency from Australian dollars to US dollars (USD) effective January 1, 2025
• Aligns with predominant currency used for revenue, costs and cash flows which are primarily generated in the US
• 2025 half-year and annual financial results to be presented in USD

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX) today announces that, effective 1 January 2025, it will change its reporting currency from Australian dollars to United States dollars (USD) in accordance with Australian Accounting Standards Board Standard 108, Accounting Policies. Changing presentation currency to USD allows the Company to align to the predominant currency used for reporting of revenue, costs and corresponding cash flows, which are primarily generated in the United States and denominated in USD. As a result, Telix's 2025 half-year and annual financial results will be presented in USD. For comparative purposes, the Company's reviewed or audited restated historical information will be included in the half-year report for the six months ending 30 June 2025 and in the Annual Report for the year ending 31 December 2025.